2024
Focus areas and methodological characteristics of North American-based health disparity research in sports medicine: a scoping review
Kliethermes S, Asif I, Blauwet C, Christensen L, Coleman N, Lavallee M, Moeller J, Phillips S, Rao A, Rizzone K, Sund S, Tanji J, Tuakli-Wosornu Y, Stafford C. Focus areas and methodological characteristics of North American-based health disparity research in sports medicine: a scoping review. British Journal Of Sports Medicine 2024, 58: 164-171. PMID: 38216322, PMCID: PMC10961938, DOI: 10.1136/bjsports-2023-107607.Peer-Reviewed Original ResearchConceptsHealth disparities researchHealth disparitiesDisparities researchConsequences of health disparitiesHealth-related outcomesCochrane Central Register of Controlled TrialsCentral Register of Controlled TrialsSystematic literature search of PubMedPeer-reviewed manuscriptsRegister of Controlled TrialsExercise medicineSystematic literature searchCINAHL PlusLiterature search of PubMedSearch of PubMedSports medicineOrganised sportCochrane Central RegisterSocioeconomic statusReview objectivesWeb of Science Core CollectionEducation levelEvidence baseInclusion criteriaFull-text
2017
Sport, sex and age increase risk of illness at the Rio 2016 Summer Paralympic Games: a prospective cohort study of 51 198 athlete days
Derman W, Schwellnus MP, Jordaan E, Runciman P, Blauwet C, Webborn N, Lexell J, Van de Vliet P, Tuakli-Wosornu Y, Kissick J, Stomphorst J. Sport, sex and age increase risk of illness at the Rio 2016 Summer Paralympic Games: a prospective cohort study of 51 198 athlete days. British Journal Of Sports Medicine 2017, 52: 17. PMID: 29074477, DOI: 10.1136/bjsports-2017-097962.Peer-Reviewed Original ResearchConceptsRio 2016 Summer Paralympic GamesIllness incidence ratesAthlete daysSummer Paralympic GamesHigh riskOlder athletesOwn medical supportProspective cohort studyElectronic data capturing systemsEpidemiology of illnessRates of illnessIllness surveillance systemDigestive systemRisk of illnessCohort studyIncidence rateIncrease riskIllness dataIllnessRespiratory systemSubcutaneous systemFemale athletesWheelchair fencingData capturing systemMedical supportHigh precompetition injury rate dominates the injury profile at the Rio 2016 Summer Paralympic Games: a prospective cohort study of 51 198 athlete days
Derman W, Runciman P, Schwellnus M, Jordaan E, Blauwet C, Webborn N, Lexell J, van de Vliet P, Tuakli-Wosornu Y, Kissick J, Stomphorst J. High precompetition injury rate dominates the injury profile at the Rio 2016 Summer Paralympic Games: a prospective cohort study of 51 198 athlete days. British Journal Of Sports Medicine 2017, 52: 24. PMID: 29030389, DOI: 10.1136/bjsports-2017-098039.Peer-Reviewed Original ResearchConceptsInjury incidence ratesHighest injury incidence rateRio 2016 Summer Paralympic GamesAthlete daysSummer Paralympic GamesFootball 5Football 7Own medical supportIndependent risk factorProspective cohort studyAcute traumatic injuryInjury prevention programsCommon anatomical areaIncidence of injuryIllness surveillance systemCohort studyCommon injuriesRisk factorsIncidence rateInjury profileTraumatic injuryInjury ratesInjury dataInjuryPrevention programs
2006
Molecular Characterization of Loss-of-Function Mutations in PCSK9 and Identification of a Compound Heterozygote
Zhao Z, Tuakli-Wosornu Y, Lagace TA, Kinch L, Grishin NV, Horton JD, Cohen JC, Hobbs HH. Molecular Characterization of Loss-of-Function Mutations in PCSK9 and Identification of a Compound Heterozygote. American Journal Of Human Genetics 2006, 79: 514-523. PMID: 16909389, PMCID: PMC1559532, DOI: 10.1086/507488.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAmino Acid SequenceCells, CulturedChild, PreschoolCholesterol, LDLFemaleHeterozygoteHumansImmunoprecipitationMaleMiddle AgedModels, MolecularMolecular Sequence DataMutation, MissensePedigreeProprotein Convertase 9Proprotein ConvertasesProtein ConformationProtein FoldingProtein TransportRecombinant ProteinsSerine EndopeptidasesConceptsProprotein convertase subtilisin/kexin type 9Low plasma levelsPlasma levelsLevels of PCSK9Function mutationsLow-density lipoprotein cholesterolConvertase subtilisin/kexin type 9Subtilisin/kexin type 9LDL-lowering therapyCoronary heart diseaseDevelopment of atherosclerosisApparent good healthCompound heterozygotesWild-type PCSK9Immunoblotting of plasmaLipoprotein cholesterolHeart diseasePCSK9 secretionType 9Confer protectionLDLGood healthElevated levelsSevere lossAttractive target